Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity

Abstract

Tumor cells able to recapitulate tumor heterogeneity have been tracked, isolated and characterized in different tumor types, and are commonly named Cancer Stem Cells or Cancer Initiating Cells (CSC/CIC). CSC/CIC are disseminated in the tumor mass and are resistant to anti-cancer therapies and adverse conditions. They are able to divide into another stem cell and a "proliferating" cancer cell. They appear to be responsible for disease recurrence and metastatic dissemination even after apparent eradication of the primary tumor. The modulation of CSC/CIC activities by the tumor microenvironment (TUMIC) is still poorly known. CSC/CIC may mutually interact with the TUMIC in a special and unique manner depending on the TUMIC cells or proteins encountered. The TUMIC consists of extracellular matrix components as well as cellular players among which endothelial, stromal and immune cells, providing and responding to signals to/from the CSC/CIC. This interplay can contribute to the mechanisms through which CSC/CIC may reside in a dormant state in a tissue for years, later giving rise to tumor recurrence or metastasis in patients. Different TUMIC components, including the connective tissue, can differentially activate CIC/CSC in different areas of a tumor and contribute to the generation of cancer heterogeneity. Here, we review possible networking activities between the different components of the tumor microenvironment and CSC/CIC, with a focus on its role in tumor heterogeneity and progression. We also summarize novel therapeutic options that could target both CSC/CIC and the microenvironment to elude resistance mechanisms activated by CSC/CIC, responsible for disease recurrence and metastases.

Cited by papers we hold 9

• Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment · 2023
  No notice
• Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches · 2021
  No notice
• Cancer Stem Cell Plasticity – A Deadly Deal · 2020
  No notice
• Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness · 2020
  No notice
• Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and Beyond · 2020
  No notice
• Extracellular vesicle-based drug delivery systems for cancer treatment · 2019
  No notice
• GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer · 2019
  No notice
• Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer · 2018
  No notice
• The Roles of ROS in Cancer Heterogeneity and Therapy · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.